Latvia vs South Asia (IDA & IBRD): Prevalence of hypertension
Latvia
43.9%
in 2019
South Asia (IDA & IBRD)
31.0%
in 2019
Latvia rank
38th
South Asia (IDA & IBRD) rank
38th
Prevalence of hypertension over time
- Latvia
- South Asia (IDA & IBRD)
How they compare
Latvia currently reports 43.9% against 31.0% in South Asia (IDA & IBRD), a difference of 12.9%.
That makes Latvia's figure about 1.4 times South Asia (IDA & IBRD)'s.
Across all 30 years both countries report, Latvia has been ahead every year.
Latvia ranks 38th and South Asia (IDA & IBRD) ranks 38th of 192 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.6% | 29.6% | 19.0% | Latvia |
| 2000s | 46.9% | 31.2% | 15.7% | Latvia |
| 2010s | 45.0% | 31.2% | 13.8% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Latvia or South Asia (IDA & IBRD)?
- Latvia, at 43.9% against 31.0% in South Asia (IDA & IBRD) as of 2019.
- What is the difference in prevalence of hypertension between Latvia and South Asia (IDA & IBRD)?
- 12.9%, with Latvia ahead.
- How many years of comparable data are there for Latvia and South Asia (IDA & IBRD)?
- 30 years are reported by both, from 1990 to 2019.
- How do Latvia and South Asia (IDA & IBRD) rank globally for prevalence of hypertension?
- Latvia ranks 38th and South Asia (IDA & IBRD) ranks 38th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.